CareLit Fachartikel
Effects of long term ToBrAmycin InhalaTion SoluTion (TIS) once daiLy on Exacerbation rate in patients with non-cystic fibrosis bronchiectasis. A doubleblind, randomized, placebo c…
L Terpstra, J Altenburg, W Boersma · Pneumologie · 2016 · Heft 10
Dokument
1176741
CareLit-ID
Jahr
2016
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Rationale: Patients with bronchiectasis often have exacerbations of their disease. These exacerbations influence the quality of life. In patients with cystic fibrosis (CF) inhaled antibiotics lower the bacterial load in bronchial secretions and have a positive effect on the number of exacerbations, lung function and quality of life (QoL). In patients with non-CF bronchiectasis colonized with Pseudomonas aeruginosa, studies with tobramycin inhalation solution (TIS) are limited. In present study the value of TIS will be investigated in patients with non-CF bronchiectasis colonized by Gram-negative bacteria and/or…
Schlagworte
Bronchiectasis
Bacterial Load
Azithromycin
Bacteria
Aged
Pneumologie
